ClinicalTrials.gg
CompletedNCT02145793Updated May 26, 2014

Exploring the Group Visit Model for Pediatric ADHD Management in the Medical Home

An interventional study of ADHD Group Curriculum in ADHD, sponsored by Indiana University. Completed at 1 site in United States. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2014-05-26.

Sponsored by Indiana University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
6 Years to 18 Years
Sex
All
01

Study summary

Attention deficit hyperactivity disorder (ADHD) affects 8% of US youth. Even though evidence shows medications are effective in reducing ADHD symptoms, many families experience ongoing parenting stress around parent-child interactions. Children often have ongoing impairments in functioning. ADHD is a common condition identified and managed by primary care pediatricians. However current care in the clinic is not optimal to address parents' and children's needs around ADHD chronic care. Time is the biggest barrier. Group visits are a viable option to improve pediatric ADHD care, but requires extensive study. The goal of this proposed study is to test the feasibility and effectiveness of the group visit model for ADHD management within pediatric primary care. This study will be a randomized feasibility study that will generate important pilot data, as well as result in an innovative, exportable pediatric ADHD group curriculum for primary care practice.

Read the detailed description

The specific research aims of this proposal are:

Aim 1: Develop and test a group curriculum for parents of children (age 6 to 18 years) with ADHD to increase parental knowledge about ADHD and self-confidence in managing issues related to their child's functioning in school and home.

Aim 2: Develop and test a group curriculum for children (age 6 to 18 years) with ADHD to teach social and educational skills to improve adaptive functioning at home and school.

Aim 3: To assess any added benefits to the parents, children and providers (related to group visit logistics and satisfaction) the group visit model has over usual care.

Aim 4: To assess whether the group visit model can be done efficiently and effectively in the setting of an actual general pediatric practice.

02

Conditions studied

  • ADHD

Keywords

  • primary care
  • pediatrics
  • parenting
  • education
03

In context

Attention Deficit Disorder with Hyperactivity

1,548 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 254 are open to participants now.

This study's enrollment of 56 is below the median of 71 across 1,233 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Indiana University is the lead sponsor of 982 studies on the registry; 199 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 117 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children with ADHD and their parents
  • children receiving routine ADHD follow-up care at the study clinic
  • if on medication, must be "stable" for 3 months and therefore not needing monthly clinic appointments to titrate medication

Exclusion criteria

Exclusion Criteria:

  • conduct disorder
  • autism
  • moderate to severe intellectual disability
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Active comparator
    ADHD Group Curriculum

    Participants assigned to the group visit intervention agree to participate in 5 group visits every 3 months rather than individual ADHD follow-up visits to the clinic. Parents and children participate in separate but simultaneously run groups. Group portion is 60 minutes and then parent-child dyads complete individual visits for medication titration and physical exam.

    Behavioral: ADHD Group Curriculum

  • No intervention
    Control

    Participants continue to go to the clinic for 5 routine ADHD follow-up visits to the clinic every 3 months as usual clinical protocol.

Interventions

  • BehavioralADHD Group Curriculum

    Study specific ADHD Group curriculum was designed and implemented for the study. Parent curriculum included the following topics: What is ADHD, medications, educational advocacy, how to prevent behavioral issues and how to defuse common behavioral challenges and manage stress. Child curriculum included the following topics: what is ADHD, social skills and friendships, handling school and organization skills, understanding feelings and managing negative emotions

06

What researchers measure

Primary outcomes

  1. Number of clinic visits during study period

    Feasibility of group visit model was measured as number of visits to the clinic by chart review. We also looked at the number of group visits a family attended based on the sign in sheet provided at the beginning of each session.

    Time frame: 12 months

Secondary outcomes

  1. Parent-rated ADHD symptoms

    Parents completed validated Vanderbilt Rating Scale regarding child's ADHD symptoms. Measures response to ADHD treatment, primarily medication.

    Time frame: Baseline

  2. Parent-rated ADHD symptoms

    Parents complete validated Vanderbilt Rating Scale to report child symptoms of ADHD. Used to assess response to treatment, usually medication.

    Time frame: 12 months

  3. Child functioning at home

    Parent report of adaptive functioning of child in the home setting using the Home Situations Questionnaire

    Time frame: Baseline

  4. Child functioning at home

    Parents report of child's adaptive functioning in the home setting using the Home Situations Questionnaire.

    Time frame: 12 months

  5. Teacher report of child's ADHD symptoms

    teachers received the validated Vanderbilt rating scale to rate student's ADHD symptoms in the classroom. Parents were given the tool at time of enrollment and asked to give to teacher as per clinical care guidelines. Monitors impact of ADHD treatment, usually medication.

    Time frame: baseline

  6. teacher report of child's ADHD symptoms in school

    teachers received the validated Vanderbilt rating scale to rate student's ADHD symptoms in the classroom. Parents were given the tool at time of enrollment and asked to give to teacher as per clinical care guidelines. Monitors impact of ADHD treatment, usually medication.

    Time frame: 12 months

  7. Child functioning at school

    teachers were invited to provide rating of child's adaptive functioning at school. Parent given the tool at time of enrollment and instructed to give to teacher as per clinical care guidelines.

    Time frame: baseline

  8. teacher rating of child's functioning in school

    teachers were invited to provide rating of child's adaptive functioning at school. Parent given the tool at time of enrollment and instructed to give to teacher as per clinical care guidelines.

    Time frame: 12 months

  9. Quality of Life

    Capture parent rating of quality of life related to ADHD using the Child Health Questionnaire-28 validated tool.

    Time frame: baseline

  10. Quality of Life

    Capture parent rating of quality of life related to ADHD using the Child Health Questionnaire-28 validated tool.

    Time frame: 12 months

  11. Parenting self-efficacy

    Parent reported sense of confidence using the Parenting Sense of Confidence Scale

    Time frame: Baseline

  12. Parenting Self-efficacy

    Parent-reported sense of confidence using Parenting Sense of Confidence scale

    Time frame: 12 months

  13. Parental knowledge, satisfaction towards medication treatment

    Parent report of knowledge, attitudes and satisfaction towards medication experiences with ADHD medication treatment

    Time frame: baseline

  14. Parent knowledge and satisfaction towards medication treatment

    Parent report of knowledge, attitudes and satisfaction towards medication experiences with ADHD medication treatment

    Time frame: 12 months

Other outcomes

  1. Participant feedback about the curriculum

    parents and children separately complete a short 4 question survey about what they liked, what they did not like, what they are excited about doing after the group visit and suggestions for improvement. Data used to continually refine the curriculum. At the 5th group visit, participants participated in informal discussion about the group visit model and overall satisfaction with the intervention

    Time frame: after each group visit over 365 days

  2. Pediatric facilitator and staff feedback

    collected informal feedback and reflection about the process, barriers and positive experiences overall about the group visit model and impact on the clinical workflow, suggestions for improvement that was used to continually refine the model for quality improvement

    Time frame: at the end of each group visit over 365 days

07

Study locations

1 site
  • General Pediatrics Clinic Medical Service Area 1 in Riley Hospital for Children at IU Health
    Indianapolis, Indiana 46202, United States
08

References and documents

Publications

  • Bauer NS, Szczepaniak D, Sullivan PD, Mooneyham G, Pottenger A, Johnson CS, Downs SM. Group Visits to Improve Pediatric Attention-Deficit Hyperactivity Disorder Chronic Care Management. J Dev Behav Pediatr. 2015 Oct;36(8):553-61. doi: 10.1097/DBP.0000000000000207. PubMed 26414089 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 26, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02145793
Lead sponsor
Indiana University
Responsible party
Nerissa Bauer (Assistant Professor, Indiana University) — Principal investigator
First posted
May 23, 2014
Start date
Jun 2012
Primary completion
Oct 2013
Completion
Nov 2013
Last update
May 26, 2014

Study contacts

Nerissa S Bauer, MD, MPH
principal investigator · Indiana University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion